###begin article-title 0
A Study on Altered Expression of Serine Palmitoyltransferase and Ceramidase in Psoriatic Skin Lesion
###end article-title 0
###begin p 1
###xml 1244 1252 <span type="species:ncbi:9606">patients</span>
Ceramides are the main lipid component maintaining the lamellae structure of stratum corneum, as well as lipid second messengers for the regulation of cellular proliferation and/or apoptosis. In our previous study, psoriatic skin lesions showed marked decreased levels of ceramides and signaling molecules, specially protein kinase C-alpha (PKC-alpha) and c-jun N-terminal kinase (JNK) in proportion to the psoriasis area and severity index (PASI) scores, which suggested that the depletion of ceramide is responsible for epidermal hyperproliferation of psoriasis via downregulation of proapoptotic signal cascade such as PKC-alpha and JNK. In this study, we investigated the protein expression of serine palmitoyltransferase (SPT) and ceramidase, two major ceramide metabolizing enzymes, in both psoriatic epidermis and non-lesional epidermis. The expression of SPT, the ceramide generating enzyme in the de novo synthesis in psoriatic epidermis, was significantly less than that of the non-lesional epidermis, which was inversely correlated with PASI score. However, the expression of ceramidase, the degradative enzyme of ceramides, showed no significant difference between the lesional epidermis and the non-lesional epidermis of psoriatic patients. This might suggest that decreased expression of SPT protein is one of the important causative factors for decreased ceramide levels in psoriasis.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 274 282 <span type="species:ncbi:9606">patients</span>
Ceramides are the main lipids in the stratum corneum, and their depletion is thought to be one of the etiological factors for barrier disruption in various levels of skin conditions (1-4). Marked depletion of ceramides in the stratum corneum has been reported especially in patients with psoriasis and atopic dermatitis.
###end p 3
###begin p 4
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 347 348 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 349 350 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 665 666 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 668 669 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 888 895 880 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Ceramides are generated by serine palmitoyltransferase (SPT), the enzyme for de novo synthesis or by the action of sphingomyelinase. As lipid second messengers, they mediate antiproliferative and apoptotic effect via activation of several signal transduction molecules such as protein kinase C-alpha (PKC-alpha) and c-jun N-terminal kinase (JNK) (5-7). In our previous study, the decreased levels of ceramide in psoriatic skin lesions were shown to be responsible for epidermal hyperplasa via downregulation of proapoptotic signal cascade such as PKC-alpha and JNK. In contrast, diacyglycerol (DAG) levels were elevated and free fatty acid levels were not changed (8, 9). However, in the past study, the ceramide level and protein expression of ceramide-metabolizing enzymes in psoriatic skin lesion was not elucidated. In the present study measured the expression of SPT, key enzyme for de novo ceramide synthesis, and ceramidase, the degradative enzyme of ceramide, in both psoriatic epidermis and non-lesional epidermis.
###end p 4
###begin title 5
MATERIALS AND METHODS
###end title 5
###begin title 6
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and skin biopsies
###end title 6
###begin p 7
###xml 354 361 354 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 46 51 <span type="species:ncbi:9606">women</span>
###xml 56 59 <span type="species:ncbi:9606">men</span>
Twenty four Korean patients with psoriasis (9 women, 15 men) ranging in age from 9 to 37 yr gave informed consent and took part in this study. All the subjects had psoriasis vulgaris as identified through clinical and histological assessment and had not been treated either systemically or topically for at least 1 month before punch biopsies were done (Table 1). Using a 4-mm punch, biopsies were taken from lesional and non-lesional skin on the lower extremities, back, or arms. The epidermis was separated as described previously (10). Specifically, the epidermis was separated from whole-skin biopsies by overnight incubation at 4â„ƒ in a 1:1 (v/v) mixture of dispase solution (Roche Molecular Biochemicals, Manheim, Germany) and Hank's balanced salt solution (HBSS; Gibco BRL, Life Technologies, Rockville, MD, U.S.A.).
###end p 7
###begin title 8
Assessing the clinical severity of psoriasis
###end title 8
###begin p 9
###xml 136 137 136 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 139 140 139 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 142 143 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sub>
###xml 153 154 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">u</sub>
###xml 156 157 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">u</sub>
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">u</sub>
###xml 162 163 162 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">u</sub>
###xml 170 171 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 173 174 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 176 177 176 177 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 179 180 179 180 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 187 188 187 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sub>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sub>
###xml 193 194 193 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sub>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sub>
###xml 913 920 913 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 636 644 <span type="species:ncbi:9606">patients</span>
###xml 706 714 <span type="species:ncbi:9606">patients</span>
###xml 903 911 <span type="species:ncbi:9606">patients</span>
###xml 927 935 <span type="species:ncbi:9606">patients</span>
The clinical severity was assessed using the psoriasis area and severity index (PASI) score, which is calculated as follows: PASI=0.1 (Eh+Ih+Dh)Ah+0.2 (Eu+Iu+Du)Au+0.3 (Et+It+Dt)At+0.4 (El+Il+Dl)Al, where E=erythema, I=infiltration, D=desquamation, A=area, h=head, u=upper extremities, t=trunk, and l=lower extremities. A numerical value is given to the extent of the lesions in each area: 1=<10%, 2=10-30%, 3=30-50%, 4=50-70%, 5=70-90%, and 6=90-100%. E, I, and D were scored on a five-point scale (0=no symptoms, 1=slight, 2=moderate, 3=marked, and 4=very marked) to obtain a final PASI score between 0 and 72. The PASI scores of the patients who took part in this study ranged between 2.0 and 27.4. The patients with PASI scores <30 were enrolled in this study in order to determine whether alterations in the levels of SPT and ceramidase are closely correlated to the clinical severity in psoriatic patients (Table 1). All patients with PASI scores >30 were excluded in this study because their skin lesions were shown to be transformed into severe variants of psoriasis, such as the erythrodermic type.
###end p 9
###begin title 10
Western blot analysis
###end title 10
###begin p 11
###xml 72 73 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 776 781 <span type="species:ncbi:9606">human</span>
###xml 1005 1016 <span type="species:ncbi:3704">horseradish</span>
###xml 1044 1050 <span type="species:ncbi:9986">rabbit</span>
Every frozen skin sample was added to 400 microL of Folch solution (CHCl3: MeOH 2:1, v/v mixture) and was homogenized using a polytron homogenizer, and 200 microL of 0.1 M KCl was added. The mixture was centrifuged at 3,000 rpm for 5 min each. The upper phase containing the extracted proteins was separated. This process was repeated one more time. The protein concentration was determined by BCA protein assay (Pierce, Rockford, U.S.A.) according to the manufacturer's protocol. Fifty micrograms of protein was fractionated on 10% Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) and transferred to a nitrocellulose membrane by electrophoresis. The membranes were blocked with 5% non-fat dry milk for 1 hr at room temperature and incubated with prepared human SPT, ceramidase, and tubulin antibody (Labfrontier, Seoul, Korea) at a 1:250 dilution with Tris-buffered saline containing 0.05% Tween-20 (TSB-T) for 1 hr. After washing with TBS-T for 1 hr, the membranes were reacted with horseradish peroxidase-conjugated anti-rabbit IgG antibody (Amersham Biosciences, Buckinghamshire, U.K.) diluted 1:250 with TBS-T for 1 hr at room temperature. After washing the membranes with TBS-T for 1 hr, the protein level was detected using the ECL chemiluminescence kit (Amersham Bioscience, Buckinghamshire, U.K.).
###end p 11
###begin title 12
Statistical analysis
###end title 12
###begin p 13
###xml 322 323 322 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 162 170 <span type="species:ncbi:9606">patients</span>
The statistical significance of the difference in the levels of SPT/tubulin and ceramidase/tubulin between the lesional and the non-lesional samples of psoriasis patients was assessed using a paired t-test. The correlations between the levels of SPT and the PASI scores were determined using the Spearman correction test. p values less than 0.05 were considered statistically significant.
###end p 13
###begin title 14
RESULTS
###end title 14
###begin title 15
Protein expression of Serine palmitoyltransferase and ceramidase in psoriatic epidermis and non-lesional epidermis
###end title 15
###begin p 16
###xml 121 127 121 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 252 258 252 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 424 430 424 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 737 743 737 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 914 921 914 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3A</xref>
###xml 923 924 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1075 1082 1075 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3B</xref>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Western blot analysis of SPT and ceramidase in the lesional and non-lesional epidermis of psoriasis patients is shown in Fig. 1, 2. When the level of SPT protein expression was quantified by densitometry and was expressed as a ratio of SPT to tubulin (Fig. 1, 2), the levels of SPT expression in the lesional epidermis was significantly lower (range, 1.26-5.59) than those in the non-lesional epidermis ( range, 4.63-9.97) (Fig. 1). In contrast, levels of ceramidase expression in the lesional epidermis ranged from 0.025 to 1.070, and those in the non-lesional epidermis ranged from 0.023 to 1.556, which indicates that there was no significant difference in the level of ceramidase of lesional and non-lesional epidermis of psoriasis (Fig. 2). After normalization with tubulin, the mean level of SPT/tubuin in the lesional epidermis was significantly decreased compared to the non-lesional epidermis as shown in Fig. 3A (p<0.05). However, there was no significant difference in the mean ratio of ceramidase to tubulin between lesional psoriatic skin and non-lesional skin (Fig. 3B).
###end p 16
###begin title 17
Correlation of SPT, ceramidase, and PASI score
###end title 17
###begin p 18
###xml 125 132 125 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 541 542 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 561 567 561 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 181 188 <span type="species:ncbi:9606">patient</span>
###xml 192 199 <span type="species:ncbi:9606">patient</span>
The protein expression of SPT and ceramidase of non-lesion and lesion, and the PASI score in psoriatic patients are shown in Table 1. Although the absolute level of SPT varied from patient to patient, SPT expression of lesional epidermis was significantly less (p<0.05) than that of non-lesional epidermis, as with the percent reduction ranging from 17.5 to 87.6. When the PASI score was applied, there was a significant negative correlation between percent reduction of SPT expression in the lesional epidermis and the PASI score (r=-0.76, p=0.01) as shown in Fig. 4. However, there was no significant correlation between percent reduction of ceramidase expression in the lesional epidermis and the PASI score.
###end p 18
###begin title 19
DISCUSSION
###end title 19
###begin p 20
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 695 696 695 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 820 822 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 823 825 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 835 842 832 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 917 919 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 922 928 919 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
The epidermis contains a large amount of sphingolipids, which are concentrated in upper, differentiated cell layer, where they are thought to participate in the maintenance of the cutaneous permeability barrier (11). Among the epidermal sphingolipids, ceramide is the main lipid in the stratum corneum and its depletion is thought to be one of the etiological factors for barrier disruption in skin conditions (1-4). Moreover, as a signal transduction molecule, ceramide is involved in the cell proliferation and apoptosis signaling pathway via activation of several signal transduction molecules, and its depletion is related with various skin disease such as atopic dermatitis or psoriasis (5-8). Synthesis of ceramide is regulated by several enzymes such as sphingomyelinase, beta-glucocerebrosidase, and ceramidase (12-15). Also a de novo pathway mediated by SPT functions as a key pathway of ceramide systhesis (16) (Fig. 5).
###end p 20
###begin p 21
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 414 419 <span type="species:ncbi:9606">human</span>
SPT is a key enzyme in sphingolipid biosynthesisis. It is the first committed and rate-limiting step in sphigolipid synthesis (17, 18). One of the substrates for SPT is various acyl-CoAs. In the mammalian cells, palmitoyl CoA is one of the most abundant acly-CoA types and it is the predominant acyl-CoA substrate of SPT in vivo (19-21). However, SPT strictly utilizes L-serine as its amino acid substate (22). In human epidermis, SPT catalyzes the palmitoyl CoA and L-serine to synthesize ceramide (17).
###end p 21
###begin p 22
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
Ceramidase hydrolyzes ceramide into shpingophosphorylcholine and free fatty acid. It is demonstrated that marked elevated activity of this enzyme is responsible for low levels of cermaide in stratum corneum of atopic dermatitis patients (23).
###end p 22
###begin p 23
###xml 281 282 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 284 285 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
In our previous study, decreased ceramide in psoriatic skin lesions is shown to be responsible for epidermal hyperplasia via downregulation of proapoptotic signal cascade such as PKC-alpha and JNK. In contrast, DAG levels were elevated and free fatty acid levels were not changed (8, 9). However, in the past study, we could not elucidate what makes ceramide decreased in psoriatic skin lesion.
###end p 23
###begin p 24
###xml 1335 1337 1335 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
In this study, we measured the expression of SPT and ceramidase in both psoriatic epidermis and non-lesional epidermis. SPT is one of the enzymes, which is related to the synthesis of ceramide, and ceramidase is a catalytic enzyme, which is related to the decrease of the levels of ceramide. The results of this experiment showed that levels of SPT were significantly decreased in the psoriatic skin. However, the levels of ceramidase showed no significant difference between psoriatic epidermis and non-lesional epidermis. We also evaluated the relationship between the PASI score and decreased levels of SPT to determine the role of decreased SPT on the severity of psoriasis. The correlation between the percentage reduction in the ratio of SPT/tubulin in the lesional epidermis and the PASI scores showed a significantly negative correlation. Considering above results, decreased levels of ceramide in psoriatic skin, as shown in our previous study, are responsible for decreased levels of SPT in psoriatic skin lesion, and their levels of reduction are highly related to the clinical severity of psoriasis. However, according to this experiment, ceramidase does not seem to have a relation with psoriatic epidermal changes, and this result is different from that of the previous study on ceramidase activity in atopic dermatitis (23).
###end p 24
###begin p 25
###xml 114 121 114 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
In conclusion, we demonstrated that the decreased levels of ceramide in the psoriatic epidermis is related to its de novo synthetic pathway, which is associated with levels of SPT, and the levels of SPT are closely related to the clinical severity of psoriasis. Considering that psoriasis is one of the inflammatory skin diseases, several cytokines or growth factors secreted by keratinocytes, Langerhans cells, or T-cells in the psoriatic skin lesion seem to affect the expression of serine palmitoyltransferase, and this postulation need further studies.
###end p 25
###begin article-title 26
Structural and lipid biochemical correlates of the epidermal permeability barrier
###end article-title 26
###begin article-title 27
Decreased levels of ceramides in stratum corneum of atopic dermatitis: an etiological factor in atopic dry skin
###end article-title 27
###begin article-title 28
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Difference in ceramide composition between "dry" and normal skin in patients with atopic dermatitis
###end article-title 28
###begin article-title 29
###xml 76 87 <span type="species:ncbi:10141">guinea pigs</span>
gamma-Linolenic acid in borage oil reverses epidermal hyperproliferation in guinea pigs
###end article-title 29
###begin article-title 30
###xml 85 90 <span type="species:ncbi:9606">human</span>
Ceramide induces translocation of protein kinase C-alpha to the Golgi compartment of human embryonic kidney cells by interacting with the C2 domain
###end article-title 30
###begin article-title 31
Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells
###end article-title 31
###begin article-title 32
Ceramide regulates cellular homeostasis via diverse stress signaling pathways
###end article-title 32
###begin article-title 33
###xml 76 84 <span type="species:ncbi:9606">patients</span>
An inverse relationship between ceramide synthesis and clinical severity in patients with psoriasis
###end article-title 33
###begin article-title 34
Ceramides and cell signaling molecules in psoriatic epidermis: reduced levels of ceramides, PKC-alpha, and JNK
###end article-title 34
###begin article-title 35
Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis
###end article-title 35
###begin article-title 36
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human stratum corneum lipids: characterization and regional variations
###end article-title 36
###begin article-title 37
Ceramide in the eukaryotic stress response
###end article-title 37
###begin article-title 38
The role of de novo ceramide synthesis in chemotherapy-induced apoptosis
###end article-title 38
###begin article-title 39
Physiology and pathophysiology of sphingolipid metabolism and signaling
###end article-title 39
###begin article-title 40
Ceramide: second messenger or modulator of membrane structure and dynamics?
###end article-title 40
###begin article-title 41
An update of the enzymology and regulation of sphingomyelin metabolism
###end article-title 41
###begin article-title 42
###xml 49 54 <span type="species:ncbi:9606">human</span>
Serine palmitoyltransferase activity in cultured human keratinocytes
###end article-title 42
###begin article-title 43
Localization of epidermal sphingolipid synthesis and serine palmitoyltransferase activity: alterations imposed by permeability barrier requirements
###end article-title 43
###begin article-title 44
The quantitation of long-chain acyl-CoA in mammalian tissue
###end article-title 44
###begin article-title 45
Improved and simplified tissue extraction method for quantitating long-chain acyl-coenzyme A thioesters with picomolar detection using high-performance liquid chromatography
###end article-title 45
###begin article-title 46
###xml 83 89 <span type="species:ncbi:9913">bovine</span>
Identification and quantitation of the fatty acids composing the CoA ester pool of bovine retina, heart, and liver
###end article-title 46
###begin article-title 47
Purification of the serine palmitoyltransferase complex responsible for sphingoid base synthesis by using affinity peptide chromatography techniques
###end article-title 47
###begin article-title 48
Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis
###end article-title 48
###begin p 49
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Western blot analysis of SPT in the lesional and the non-lesional epidermis of posriasis patients. Western blotting was performed using anti-SPT antibodies, as described in Materials and Method. The level of SPT expression was quantified by densitometry and is expressed as ratio of SPT and tubulin. *, significant differences between lesional epidermis and non-lesional epidermis (p<0.05).
###end p 49
###begin p 50
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Western blot analysis of ceramidase in the lesional and the non-lesional epidermis of posriasis patients. Western blotting was performed using anti-ceramide antibodies, as described in the Materials and Method. The level of ceramidase expression was quantified by densitometry and is expressed as a ratio of ceramidase and tubulin. However, we could not find any statistically significant difference between two groups.
###end p 50
###begin p 51
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 232 233 232 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
(A) The mean ratio of SPT and tubulin of the lesional epidermis was significantly decreased compared to that of the non-lesional epidermis. *, significant differences between lesional epidermis and non-lesional epidermis (p<0.05). (B) However, there was no significant difference between the mean ratio of ceramidase to tubulin in the lesional epidermis and that of the non-lesional epidermis.
###end p 51
###begin p 52
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 133 141 <span type="species:ncbi:9606">patients</span>
Correlation between the percentage reduction in the ration of SPT/tubulin in the lesional epidermis and the PASI scores of psoriasis patients. A significant negative correlation was observed (Spearman's rho=-0.76, p=0.01).
###end p 52
###begin p 53
###xml 132 139 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
The synthesis of ceramide is regulated by several enzymes such as sphingomyelinase, beta-glucocerebrosidase, and ceramidase. Also a de novo pathway mediated by serine palmitoyltransferase (SPT) functions as the key pathway of ceramide systhesis. SM, spingomyelin; SPT, serine palmitoyltransferase.
###end p 53
###begin p 54
SPT, ceramidase, and PASI score
###end p 54
###begin p 55
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 120 126 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
###xml 241 254 236 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8225;</sup>
*Significant difference of SPT/tubulin levels between the lesional epidermis and non-lesional epidermis (n=24, p<0.05). daggerThe percent reduction was calculated as (SPT/tubulin in lesion divided by SPT/tubulin in non-lesional level)x100 . double daggerThe percent reduction or increase was calculated as (ceramidase/tubulin in lesion divided by ceramidase/tubulin in non-lesional level)x100. S, serine palmitoyltransferase; T, tubulin; C, ceramidase.
###end p 55

